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1. Introduction 
Most microorganisms that are encountered in the daily life of a healthy individual are 
detected and destroyed within minutes or hours by the defence mechanisms of the innate 
immunity. Macrophages play a key role in innate immunity because they can recognize, 
ingest and destroy many pathogens without the aid of an adaptive immune response. 
Macrophages recognize pathogens via cell-surface receptors that can discriminate between 
the surface molecules displayed by pathogens and those of the host (Bryant & Fitzgerald, 
2009). Binding of bacteria to macrophage receptors stimulates phagocytosis and uptake of 
pathogens into intracellular vesicles, where they are destroyed (Groves et al., 2008). Upon 
phagocytosis macrophages produce a variety of toxic products that help to kill the engulfed 
microorganisms. The most important of these are antimicrobial peptides, nitric oxide (NO), 
the superoxide anion (O2-), hydrogen peroxide (H2O2), the hydroxyl radical (·OH), 
hypochlorite (OCl-) and hypobromide (OBr-), which are directly toxic to bacteria (Pourova et 
al., 2010; Robinson, 2009). In addition, activation of macrophage receptors triggers the 
production of pro-inflammatory cytokines and chemokines (including IL-1ǃ, IL-6, TNF-ǂ 
and CXCL8) (Hamilton et al., 1999) and the expression of co-stimulatory molecules such as 
B7.1 and B7.2 (Glaros et al. 2009), which orchestrates immune responses. 
Fatty acids are indispensable to life for all organisms. They serve as a source of metabolic 
energy providing twice the energy density compared to carbohydrates or proteins. In 
addition, fatty acids are an integral part of cellular membranes. The heterogeneity of fatty 
acids in the membrane contributes to membrane fluidity as well as to the physical and 
chemical properties of various membrane domains (Stillwell & Wassall, 2003; Wassall & 
Stillwell, 2008). Numerous cellular functions critically rely on the dynamic characteristics of 
the membranes. Thus, fatty acids are important for signalling mechanisms as well as 
catalytic processes by membrane-associated enzymes (Stillwell & Wassall, 2003; Wassall & 
Stillwell, 2008). The oxygenated derivatives of some fatty acids include prostaglandins, 
prostacyclins, thromboxanes and leukotrienes, lipoxins, resolvins, protectins and marensins 
(Bannenberg & Serhan, 2010; Kohli & Levy, 2009; Löffler et al., 2007; Norling & Serhan, 
2010). This group of biological messenger substances mediate numerous and diverse actions 
especially in the immune system (Bannenberg & Serhan, 2010; Kohli & Levy, 2009; Löffler et 
al., 2007; Norling & Serhan, 2010). 
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Diseases occur when a microorganism succeeds in evading or overwhelming innate host 
defences to establish a local site of infection, and then replicates there to allow its further 
transmission within the body. Immunocompromised individuals are in special danger in 
developing serious illness (Kamboj, et al., 2005; Prescott, 1991; Trautmann et al., 2005). 
Immune cell activity depends on numerous external as well as internal stimuli. One 
important factor modulating immune function is the diet. In particular, nutritional fatty 
acids have an impact on membrane fatty acid composition. Basic properties of membranes, 
including fatty acid chain order, phase behaviour, elastic compressibility, ion permeability, 
fusion, rapid flip-flop as well as protein function are determined by the lipid composition 
(Stillwell & Wassall, 2003; Wassall & Stillwell, 2008). Accordingly, changes in membrane 
fatty acid pattern may impact cell signalling pathways and membrane-associated enzymes 
via modulating membrane fluidity (Stillwell & Wassall, 2003; Wassall & Stillwell, 2008). The 
interrelation between dietary fatty acids, membrane composition and macrophage function 
provides a link between dietary fatty acid uptake, inflammation and immunity. 
1.1 Innate immunity 
The innate immunity is the frontline in the host`s immune response. After infection the 
innate immunity detects and destroys invading microorganisms within minutes or hours. 
Only if the pathogen overwhelms the innate immunity an adaptive immune response is 
needed. 
A typical attribute of the innate immunity is its efficiency in fighting a wide variety of 
pathogens. The differentiation between self and non-self is based on a limited and invariant 
repertoire of pattern recognition receptors (PRRs) (Bryant & Fitzgerald, 2009). These 
receptors bind evolutionary conserved regular molecular structures, the so called pathogen-
associated molecular patterns (PAMPs) (Bryant & Fitzgerald, 2009). In general, PAMPs 
represent typical structures on the surface of microorganisms, which are not found on host 
cells. This includes peptidoglycane, lipopolysaccharide (LPS), mannose-rich 
oligosaccharides and un-methylated GC-rich DNA (Mogensen, 2009). 
The innate immunity is based on leucocytes of the myeloide cell line: macrophages, 
granulocytes (neutrophil, eosinophil, basophil), mast cells and dendritic cells. Macrophages 
and neutrophil granulocytes are predominantly phagocytes. They engulf pathogens and 
destroy them inside (Silva, 2010). Premature dendritic cells are phagocytes as well (Miloud 
et al., 2010). After maturing dendritic cells function as antigen presenting cells (Miloud et al., 
2010). Eosinophil and basophil granulocytes as well as mast cells are characterized by a 
great amount of secretory granula (Boyce et al., 2009). Eosinophils are thought to play an 
important role in the immune defence against parasites (Boyce et al., 2009). Mast cells 
promote locale inflammation in tissues (Boyce et al., 2009). 
1.2 Macrophages 
Macrophages (figure 1) are migrating mononuclear phagocytes, which appear throughout 
the body. In particular, macrophages can be found in high numbers in connective tissue, in 
the submucosa of the intestinal tract, in the lung, in the liver, in the spleen and along specific 
blood vessels (Varol et al., 2009). Macrophages function as pathogen-recognitive and 
antigen-presentating scavenger cells (Russel et al., 2009). In addition, macrophages serve as 
a source of pro-inflammatory cytokines as IL-1ǃ, IL-6, TNF-ǂ and CXCL8 (Hamilton et al., 
1999). The cells are crucial for engulfment and killing of invading microorganisms and for 
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orchestrating the immune response (Russel et al., 2009). At this, macrophages trigger the 
initiation of inflammatory processes via secretion of pro-inflammatory signal proteins, 
which activates further immune cells (Hamilton et al., 1999). A special function of 
macrophages is the clearance of the body from dead cells and cell debris (Russel et al., 2009). 
 
 
Fig. 1. Macrophages of the murine cell line RAW264.7 (phase-contrast). 
Macrophages express several cell-surface receptors, which can discriminate numerous 
bacterial components as bacterial carbohydrates (mannose receptor, glucan receptor), 
bacterial lipids (LPS receptors) as well as other structures typically found on pathogen 
surfaces (Toll-like receptors, scavenger receptors) (Bryant & Fitzgerald, 2009). The binding 
of a bacterium to a macrophage receptor stimulates the engulfment of the pathogen into 
intracellular vesicles, a process known as phagocytosis (Groves et al., 2008) (figure 2). The 
phagocytosis is an active process. Initially, the receptor-bound pathogen is surrounded by 
the membrane of the phagocyte. This is followed by an internalisation of the pathogen 
into an intracellular vesicle, the so called phagosom. The destruction of the 
microorganism in the phagosom occurs via lowering of the pH (Haas, 2007). Furthermore, 
the phagosom fuses with lysosomes, which enables the killing of the pathogen via 
lysosomal enzymes (Haas, 2007). 
 
 
Fig. 2. Macrophage of the murine cell line RAW264.7 during phagocytosis (phase-contrast). 
Macrophages produce a variety of toxic substances to kill engulfed microorganisms (figure 3). 
This includes antimicrobial peptides, nitric oxide (NO), the superoxide anion (O2-) and 
hydrogen peroxide (H2O2) (Pourova et al., 2010; Robinson, 2009). Nitric oxide is generated 
by the inducible nitric oxide synthase (iNOS) (Pourova et al., 2010; Robinson, 2009). 
Superoxide is synthesized by a multicomponent, membrane-associated NADPH oxidase in a 
process known as the respiratory burst, and further converted by the enzyme superoxide 
dismutase into H2O2 (Pourova et al., 2010; Robinson, 2009). Based on H2O2 a range of toxic 
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chemicals, including the hydroxyl radical (·OH), hypochlorite (OCl-) and hypobromide 
(OBr-) are produced by chemical and enzymatic reactions (Pourova et al., 2010; Robinson, 
2009). Moreover, the activation of macrophages receptors promotes the expression of co-
stimulating molecules as B7.1 and B7.2 (Glaros et al. 2009). 
 
 
Fig. 3. Macrophages of the murine cell line RAW264.7 stimulated with phorbol-myristate-
acetat (PMA). Intracellular respiratory burst is detected by the fluorogenic probe 
dihydrorhodamine 123. 
A: Phase-contrast; B: Fluorescence channel Cy3; C: Overlay 
2. Inflammation and bacterial resistance 
2.1 Characteristics of an inflammation 
An inflammation is defined as a local accumulation of fluid, plasma proteins and leucocytes 
caused by physical injuries, infections or locale immune reactions (Johnston et al., 2007). 
Characteristics of an inflammation are redness, swelling, heat and pain. During an acute 
inflammation the host actively fights invading microorganisms. This includes the inhibition 
of infection spread by means of physical barriers and the activation of the complement 
system (Johnston et al., 2007). The process is triggered by macrophage secreted cytokines 
(Johnston et al., 2007). 
2.2 Bacterial resistance mechanisms 
Several pathogens have evolved resistance mechanism to escape the immune defence 
(Johnston et al., 2007). Such persistent microorganisms are the cause of chronic infections. A 
chronic infection is a protracted process. Characteristics are an ongoing tissue damage 
accompanied with permanent proliferation processes (Germolec et al., 2010). 
Bacterial resistance mechanisms are important factors of virulence, which have a significant 
impact on infection outcome. Via interaction with the immune system pathogens are able to 
modulate the defence mechanisms of the host thereby influencing the severity of disease 
(Veesenmeyer et al., 2009). Both the rate of pathogen elimination as well as the scale of tissue 
damage can be manipulated by the microorganisms. There is a multitude of bacterial 
resistance mechanisms. Typical examples are listed in table 1. 
The impermeability of the membrane and the active transport of antimicrobial substances 
out of the cell impair the accumulation of antibiotics in the pathogens inside. Bacterial 
resistances against ǃ-lactam antibiotics, fluoroquinolones, tetracyclines and aminoglycosides 
have been reported to be based on these mechanisms (Strateva & Yordanov, 2009). 
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Bacterial resistance mechanisms 
Reduced permeability of the outer membrane 
Constitutive (over-)expression of efflux channel proteins with broad substrate specifity 
Biofilm formation 
Quorum sensing 
Table 1. Bacterial resistance mechanisms (Veesenmeyer et al., 2009; Strateva & Yordanov, 
2009) 
Via biofilm formation bacteria are able to colonise on all types of animal tissue, plants and 
inert surfaces (Boyen et al., 2009; Veesenmeyer et al., 2009). Furthermore, the resistance of 
the microorganisms against environmental conditions is improved. Biofilm formation 
hampers the killing of the pathogens by immune defence mechanisms or antimicrobial 
substances (Boyen et al., 2009; Veesenmeyer et al., 2009). As a consequence there are chronic 
infections, which are hard to treat by the means of antibiotics (Boyen et al., 2009; 
Veesenmeyer et al., 2009). 
Quorum sensing is a communication mechanism, which is used by bacteria for collective 
coordination (Boyen et al., 2009). The microorganisms produce chemical signalling 
molecules as polypeptides (auto-inducing polypeptides. AIPs), N-acetyl-homoserine-lactone 
(auto inducer-1, AI-1) or furanosyl-borate-ester (auto inducer-2, AI-2) and secret them into 
the environment (Boyen et al., 2009). When exceeding a critical concentration the signal 
molecules modulate gene expression of the bacteria thus synchronising the behaviour of the 
whole population (Boyen et al., 2009). By this way quorum sensing promotes biofilm 
formation and manipulates virulence, mobility and sporulation of the microorganisms 
(Boyen et al., 2009). 
2.3 Examples 
2.3.1 Rhodococcus equi 
Infections of immunocompetent humans with R. equi are rare. However, in case of immune-
suppressing conditions as transplantations, cancer treatment and steroid medication 
pneumonia caused by R. equi have been observed (Kamboj, et al., 2005; Prescott, 1991). HIV 
positive people are particularly endangered. The mortality rate of infected AIDS patients is 
reported to be about 55% (Bell et al., 1998). 
The facultative intracellular bacterium is known to survive extreme environmental 
conditions as low pH (Benoit, 2000) or oxidative stress (Benoit, 2002). In addition, R. equi 
blocks the process of phagosom maturation thus surviving and proliferating within 
macrophages (Fernandez-Mora et al., 2005). Internalised viable R. equi organisms prevent 
the fusion of their phagosom with lysosomes leading to an arrested phagosom neutral in pH 
and without lysosomal contents (Fernandez-Mora et al., 2005). The underlying mechanisms 
are not known, so far. 
2.3.2 Pseudomonas aeruginosa 
P. aeruginosa is one of the leading hospital bugs in the world. According to estimates the 
microorganism accounts for 10 to 15% of all nosocomial infections (Blanc et al., 1998). P. 
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aeruginosa colonises burns and wounds as well as the respiratory tract and the urinary 
tract of immunocompromised individuals (Trautmann et al., 2005). Due to the natural 
resistance of the opportunistic pathogen against numerous antibiotics P. aeruginosa 
infections are often hard to treat (Strateva & Yordanov, 2009). Moreover, the 
microorganism has a remarkably ability to acquire further resistance mechanisms against 
antimicrobial substances by the means of mutations (Strateva & Yordanov, 2009). Another 
notorious characteristic of P. aeruginosa is the biofilm formation (Boyen et al., 2009). The 
colonisation of surfaces of surgical implants, endotracheal tubes, catheters as well as the 
respiratory tract of individuals suffering from cystic fibrosis becomes an increasing 
medical problem. Further virulence factors of P. aeruginosa include the secretion of a 
number of toxins and the expression of flagella and type IV pili, which are of importance 
for surface attachment (Veesenmeyer et al., 2009). Two quorum sensing mechanisms of P. 
aeruginosa have been identified, so far: Las and Rhl (Veesenmeyer et al., 2009). A 
Pseudomonas quinolone signal (PQS) acts as mediator between the two systems (Pesci et 
al., 1999). Quorum sensing controls about 350 genes of P. aeruginosa (approximately 6% of 
the entire genome) modulating toxin synthesis and biofilm formation (Veesenmeyer et al., 
2009). 
3. Fatty acids and cellular membranes 
3.1 Fatty acids 
Fatty acids are composed of a hydrocarbon chain and a carboxyl group. Most naturally 
occurring fatty acids have a chain of an even number of carbon atoms. Fatty acids may be 
saturated or unsaturated depending on the existence of double bonds. In almost every 
unsaturated fatty acid the double bonds are in cis configuration (Löffler et al., 2007). This 
means that the adjacent hydrogen atoms are on the same side of the double bond resulting 
in a rigid binding, which restricts the conformational freedom of the fatty acid. The more cis 
double bonds a chain has, the less flexible it is. Thus, cis bonds limit the ability of a fatty acid 
to be closely packed (Stillwell & Wassall, 2003). Since fatty acids are parts of triglycerides in 
lipid droplets as well as of phospholipids in lipid bilayers the number of cis bonds of a fatty 
acid has an impact on basic physical properties of fat or biological membranes (Stillwell & 
Wassall, 2003). 
Depending on the position of the double bonds unsaturated fatty acids are classified in 
several fatty acid families: n3, n6, n7 and n9. This terminology is based on the first double 
bond relative to the end of the hydrocarbon chain. For example, the term n3 signifies that 
the first unsaturation exist at the third carbon-carbon bond from the terminal methyl end of 
the chain. A transformation of a fatty acid from one family to another is not possible (Löffler 
et al., 2007). Animals and humans lack the ability to introduce double bonds in fatty acids 
beyond carbon 9. So, the fatty acids linoleic acid (C18:2n6) and linolenic acid (C18:3n3) are 
essential to the animal and human organisms (Löffler et al., 2007). Important examples of 
the n3, the n6, the n7 and the n9 family are listed in table 2. 
Fatty acids are of great importance as membrane compound and in energy metabolism in 
the animal and human organisms. They can be found both as free fatty acids and as parts of 
acylglycerols, phospholipids, sphingolipids and cholesterol esters. Furthermore, some fatty 
acids serve as precursors of eicosanoid synthesis. 
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Non-scientific name 
Chemi-
cal 
formula
Structural formula 
N3 family   
     Linolenic acid (LNA) C18:3n3  
     Eicosapentaenoic acid (EPA) C20:5n3  
     Docosahexaenoic acid (DHA) C20:6n3  
N6 family   
     Linoleic acid (LA) C18:2n6  
     Gamma-linolenic acid (Ǆ-LNA) C18:3n6  
     Arachidonic acid (AA) C20:4n6  
N7 family   
     Palmitoleic acid C17:1n7 
N9 family   
     Oleic acid (OA) C18:1n9  
Table 2. Important examples of the n3, the n6, the n7 and the n9 fatty acid family 
3.2 Cellular membranes 
Cellular membranes are essential to life for all living beings. In prokaryotic organisms the 
plasma membrane separates the inner of the cell from the environment. In eukaryotic 
organisms beyond that there are additional intracellular membranes which encompass the 
cell organelles leading to a compartmentalisation of the cell. Furthermore, in eukaryotic 
organisms there are numerous membrane-enclosed vesicles, which ensure the directed 
exchange of materials and membrane components between the compartments of the cell as 
well as between the cell and the environment. 
Membranes serve diverse functions in prokaryotic and eukaryotic cells. The plasma 
membrane is selectively-permeable to ions and organic molecules thus controlling the 
movement of substances in and out the cell. Biological membranes are involved in a variety 
of cellular processes as cell adhesion, ion conductivity and cell signalling. Moreover, 
membranes serve as an attachment surface both extracellular and intracellular. 
The basic structure of biological membranes is a lipid bilayer, which is composed of 
phospholipids and sphingolipids. Further components of cellular membranes are 
cholesterol and proteins. Cholesterol crucially impacts the viscosity of the membrane. The 
hydrophobic interactions between the sterol scaffold of the cholesterol and the acyl chains of 
the phospholipids reduce the deformability of the lipid bilayer as well as the permeability of 
the membrane for small hydrophilic molecules (Quinn & Wolf, 2009). The proteins are the 
key to the overall functions of the membranes. They are either embedded into the 
membrane (integral proteins) or associated to it (peripheral and lipid-anchored proteins). 
Actions of membrane proteins include cell-cell contact, surface recognition, cytoskeleton 
contact, signalling, enzymatic activity and the transport of substances across the membrane. 
 COOH 
 COOH 
 
COOH 
 
COOH 
 COOH 
 COOH 
 COOH 
 COOH 
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Beside cholesterol the physical and chemical properties of biological membranes are 
determined by the fatty acid pattern. The packing density of saturated fatty acids differs 
widely from the packing density of unsaturated fatty acids (Stillwell & Wassall, 2003). An 
increase in the proportion of unsaturated fatty acids therefore results in a weakening in the 
intermolecular hydrophobic interactions (Stillwell & Wassall, 2003). In this way basal 
properties of biological membranes are modulated including the assembly of the acyl 
chains, the fluidity, permeability and compressibility of the membrane, melting and flip-flop 
mechanisms as well as the function of membrane proteins (Stillwell & Wassall, 2003; Wassall 
& Stillwell, 2008). 
3.3 Lipid rafts 
The phospholipids and sphingolipids are not distributed evenly in cellular membranes. Via 
lateral interactions among one another as well as with proteins specific micro domains are 
formed, the so called lipid rafts. Lipid rafts are structurally and functionally distinct 
domains that can be distinguished within the cell membrane due to their specific lipid 
compositions (Henderson et al., 2004; Lingwood & Simons, 2010; Pike, 2003; Tresset, 2009). 
Sphingolipids, cholesterol and saturated fatty acids predominate in the rafts (Pike, 2003). 
This allows for a tight packing of the acyl chains. The remaining liquid-ordered domain is 
characterized by a reduced fluidity compared to the surrounding plasma membrane. 
Lipid rafts have been defined as “small (10-200 nm), heterogeneous, highly dynamic, sterol- 
and sphingolipid-enriched domains that compartmentalise cellular processes” (Pike, 2006). 
A variety of proteins has been shown to be enriched in membrane rafts such as GPI-
anchored proteins, flotillin, receptor tyrosine kinases and G protein-coupled receptors (Pike, 
2003). The spatial proximity of the proteins in the rafts enables a better coordination and an 
increased efficiency of proceeding reactions. Taking the dynamic nature of membrane 
domains into account the rafts have been supposed to scaffold certain molecules while 
excluding others thus function as a unique signalling platform (Ye et al., 2010). Further 
cellular processes lipid rafts have been implicated include membrane trafficking, molecular 
sorting, internalisation processes as well as membrane-cytoskeleton interactions (Simons & 
Toomre, 2000). 
A number of macrophage functions have been shown to interrelate with membrane rafts. 
Examples include the endotoxin-mediated activation of macrophages, the MHCII-mediated 
presentation of antigens, phagocytosis as well as the production of pro-inflammatory 
cytokines (Gaus et al., 2005). Furthermore, lipid rafts have been shown to be used as target 
by a wide variety of pathogens to invade host cells (Hartlova et al., 2010). Bacterial toxins 
have been demonstrated to enter cells via certain toxin-associated receptors, which are 
known to be concentrated in membrane rafts (Van & Leo, 2002). Thus, the domains play an 
important role in infectious biology. 
4. Fatty acid dependent modulation of the immune system 
4.1 Fatty acids and the immune system 
Fatty acids, in particular polyunsaturated fatty acids (PUFAs), possess immune modulating 
properties. PUFAs are shown to modulate the proliferative activity of neutrophil 
granulocytes (Prescott, 1984), macrophages (Hughes & Pinder, 2000), T cells (Anderson & 
Fritsche, 2004) and dendritic cells (Zeyda et al., 2005). Furthermore, impacts on the 
respiratory burst, the production of cytokines as well as the expression of adhesion 
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molecules have been described (Calder, 1998; Calder, 2006a). Of note, the effects triggered 
by the fatty acids depend on the fatty acid family. N3 fatty acids such as eicosapentaenoic 
acid (C20:5n3; table 2) and docosahexaenoic acid (C22:6n3; table 2) are thought to act anti-
inflammatory (Calder, 2006a; Schmitz & Ecker, 2008). In contrast, fatty acids from the n6 
family such as linoleic acid (C18:2n6; table 2) and arachidonic acid (C20:4n6; table 2) are 
described to act pro-inflammatory (Calder, 2006a; Schmitz & Ecker, 2008). 
The interaction between fatty acids and the immune system is based on three known 
mechanisms (Benatti et al., 2004; Capkin et al, 2009): First, some fatty acids, e.g. 
eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid, serve as precursors for 
the production of immune-modulating effectors. Second, fatty acids directly interact with 
intracellular receptors such as peroxisome proliferator-activated receptors (PPARs) or 
retinoid X receptors (RXRs) as well as G protein-coupled receptors (GPR120) (Oh et al., 
2010). Third, the fatty acid composition of cell membranes modulates basic properties of the 
membrane thus influencing the activity of immune cells. A molecular model displaying the 
functional mechanisms, which underlay the interaction of fatty acids and the immune 
system, is shown in figure 4. 
 
 
Fig. 4. Molecular model displaying the functional mechanisms, which underlay the 
interaction of fatty acids and the immune system 
4.2 Eicosanoids, lipoxins, resolvins, protectins and marensins 
Unsaturated fatty acids serve as precursors for the synthesis of several signal molecules and 
tissue hormones. These lipid mediators include the eicosanoids, the lipoxins, the resolvins, 
the protectins and the marensins. 
There are four families of eicosanoids: prostaglandins, prostacyclins, thromboxanes and 
leukotrienes (Löffler et al., 2007). Each of these families can further be divided into separate 
series depending on the fatty acid family they derive from. The eicosanoid series differ 
widely in their biological activity. In general, n6 eicosanoids act pro-inflammatory, n3 
eicosanoids are much less inflammatory (Lee, 1984; Lee, 1988).  
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Eicosanoids are synthesized in almost every animal and human tissue modulating 
numerous hormonal and other stimuli. The several physiological effects are triggered by 
specific membrane receptors of target cells and target tissues (Löffler et al., 2007). Acting as 
immune-modulators and neurotransmitters among others they influence the contraction of 
smooth muscle cells (vasoconstriction / vasodilatation), the experience of pain and the 
platelet aggregation (Löffler et al., 2007). Moreover, eicosanoids play an important role in 
hypersensitivity reactions and inflammatory processes (Benatti et al., 2004). An overview on 
the biological effects of major eicosanoids is shown in table 3. 
 
Substance Biological activity 
Prostaglandin E2 
Bronchodilatation, Vasodilatation, Inducing of inflammation, fever and 
pain, Activation of osteoclasts, Inhibition of chloride secretion in the 
stomach and of lipolysis in fat tissue 
Prostaglandin D2 Bronchoconstriction, Promotion of sleep 
Prostaglandin F2ǂ 
Bronchoconstriction, Vasoconstriction, Constriction of smooth muscle 
cells 
Thromboxane A2 Bronchoconstriction, Vasoconstriction, Platelet aggregation 
Prostacyclin I2 
Vasodilatation, Increasing of vascular permeability, Inhibition of platelet 
aggregation, Inducing of inflammation 
Table 3. Biological effects of major eicosanoids (Löffler et al., 2007) 
The half-life of eicosanoids is about seconds to minutes. Thus, eicosanoids are considered as 
tissue hormones acting in an autocrine and paracrine manner (Löffler et al., 2007). The effect 
profile of eicosanoids therefore crucially depends on the type of eicosanoid receptors, which 
are expressed in close proximity to the eicosanoid-producing cell. In general, eicosanoid 
receptors are seven transmembrane receptors, which are also known as G protein-coupled 
receptors (Löffler et al., 2007). Subject to the type of receptor ligand binding results either in 
the modulation of the adenylate cyclase, which is followed by increased or decreased 
intracellular cAMP concentrations, or in an activation of the phosphatidylinositol cycle, 
which manipulates the concentration of cellular calcium (Löffler et al., 2007). 
Depending on the fatty acid, which is used as precursor, eicosanoid synthesis results in 
discrete mediators. The n6 PUFA arachidonic acid is the substrate for production of series 2 
prostaglandins and series 4 leukotrienes (Benatti et al., 2004). Starting from the n3 PUFA 
eicosapentaenoic acid series 3 prostaglandins and series 5 leukotrienes are formed (Benatti 
et al., 2004). In comparison to the arachidonic acid derivates series 3 prostaglandins and 
series 5 leukotrienes are notably less inflammatory. As an example: the leukotriene B5 has 
been reported to have a 10 to 100 times reduced biological activity than the leukotriene B4 
(Lee et al., 1984; Lee et al., 1988). 
Beside eicosanoids there is a genus of specialized pro-resolving mediators (SPM). The 
several families of these distinct local mediators include the lipoxins, the resolvins, the 
protectins and the marensins (Bannenberg & Serhan, 2010; Kohli & Levy, 2009; Norling & 
Serhan, 2010). SPM play a key role in the endogenous down-regulation of inflammation. For 
a long time inflammation resolution has been thought to occur passively by a dilution of 
pro-inflammatory signals and mediators. Only recently it has emerged, that instead it is an 
active process, which is orchestrated by a distinct set of chemical effectors (Serhan et al., 
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2008). In resolving tissues an alteration in PUFA metabolism has been observed. A class 
switching in lipid mediator generation occurs, that leads to a change in enzymatic PUFA 
conversion from pro-inflammatory eicosanoids to pro-resolving mediators (Levy et al., 
2001). SPM are derived from the n6 PUFA arachidonic acid and the n3 PUFAs 
eicosapentaenoic acid and docosahexaenoic acid as well (Bannenberg & Serhan, 2010; Kohli 
& Levy, 2009; Norling & Serhan, 2010). They exert influence at even picomolar to nanomolar 
concentrations (Serhan, 2005; Spite, 2009). Biological actions of SPM include the down-
regulation of cell adhesion molecules, the reduction of chemotaxis, transendothelial 
migration and neutrophil activation, the stimulation non-phlogistic phagocytosis of 
apoptotic neutrophils and macrophages as well as the removal of inflammatory leukocytes 
(Bannenberg & Serhan, 2010). In table 4 there is an overview regarding the biological 
activities of major SPM. 
The first SPM identified are the lipoxins (Serhan, 2005). Lipoxins are enzymatically 
generated by lipoxygenase from the n6 PUFA arachidonic acid, a process, which is triggerd 
by aspirin (Chiang, 2004). The potent anti-inflammatory effectors are special important in 
slowing down neutrophil-mediated tissue injury. They limit the recruitment and the 
adhesion of neutrophils to the site of inflammation. Furthermore, lipoxins force the 
phagocytosis of apoptotic neutrophils (Bannenberg & Serhan, 2010; Norling & Serhan, 2010). 
Major lipoxins are Lipoxin A4 (LXA4) and Lipoxin B4 (LXB4). 
Resolvins are bioactive metabolites, which are synthesized from the enzymatic conversion of 
the n3 PUFA eicosapentaenoic acid and docosahexaenoic acid. The term resolvin is derived 
from 'resolution phase interaction products' (Serhan & Chiang, 2008). Depending on the 
fatty acid they are produced from resolvins are categorized as either E-series (from 
eicosapentaenoic acid) or D-series (from docosahexaenoic acid) (Serhan & Chiang, 2008). 
Aspirin-triggered forms have been described for each family (Serhan & Chiang). The E-
series resolvins currently comprise Resolvin E1 (RvE1) and Resolvin E2 (RvE2). The D-series 
resolvins include Resolvin D1 (RvD1), Resolvin D2 (RvD2), Resolvin D3 (RvD3) and 
Resolvin D4 (RvD4). In general, resolvins efficiently block the synthesis of pro-inflammatory 
mediators, regulate the entry of neutrophils to inflammatory sites and help to clear 
neutrophils from mucosal surfaces (Norling & Serhan, 2010). At this, the bioactivity of the 
anti-inflammatory effectors has been shown to be highly stereoselective both in vitro and in 
vivo (Levy, 2010). 
The n3 PUFA docosahexaenoic acid serves also as precursor for the synthesis of protectins. 
Protectins are characterized by their anti-inflammatory and protective actions, especially in 
neuronal tissues (Hong et al., 2003). As lipoxins and resolvins, protectins stop the infiltration 
of neutrophils and activate the resolution of inflammation (Hong et al., 2003; Serhan et al., 
2006). The major protectin, Protectin D1 (PD1) has been shown to possess protective actions 
in the lung and in renal tissues thereby preserving them against injury and inflammation 
(Bannenberg & Serhan, 2010; Kohli & Levy, 2009; Levy, 2010; Norling & Serhan, 2010). 
Recently, macrophages have been identified to synthesize anti-inflammatory and pro-
resolving mediators from docosahexaenoic acid in a separate biosynthetic pathway (Norling 
& Serhan, 2010). These effectors have been termed maresins, for 'macrophage mediators in 
resolving inflammation' (Norling & Serhan, 2010). The production of marensins is triggered 
during phagocytosis (Bannenberg & Serhan, 2010). So far, Marensin 1 (MaR1), the major 
marensin, is known to reduce neutrophil migration and to stimulate phagocytosis by 
macrophages (Bannenberg & Serhan, 2010). 
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Substance Biological activity 
Resolvin E1 
Decreasing of migration, pro-inflammatory signalling and infiltration of 
neutrophils; Stimulation of phagocytosis of apoptotic neutrophils by 
macrophages; Promotion of healing of diseased tissue 
Resolvin E2 Decreasing of neutrophil infiltration 
Resolvin D1 
Decreasing of neutrophil infiltration; Protection from tissue damage and 
loss of function 
Protectin D1 
Decreasing of neutrophil infiltration and pro-inflammatory signalling; 
Stimulation of phagocytosis of apoptotic neutrophils by macrophages; 
Protection from tissue damage and loss of function 
Table 4. Biological effects of major specialized pro-resolving mediators (SPM) (Kohli & Levy, 
2009; Norling & Serhan, 2010) 
The type of eicosanoids and specialized pro-resolving mediators produced depend on the 
fatty acid composition of the cell membrane. The main phospholipase, the phospholipas A2, 
preferably liberates the n6 PUFA arachidonic acid from membrane phospholipids, which 
acts as substrate for the synthesis of series 2 prostaglandin, series 4 leukotrienes and lipoxins 
(Löffler et al., 2007). Intake of n3 PUFA, such as eicosapentaenoic acid and docosahexaenoic 
acid, leads to increased levels of these fatty acids in the cell membrane. Products of 
eicosapentaenoic acid and docosahexaenoic acid are series 3 prostaglandins, series 5 
leukotrienes, resolvins, protectins and marensins. 
4.3 Interaction of fatty acids with nuclear receptors and G protein-coupled receptors 
Fatty acids regulate gene expression via interaction with nuclear receptors and G protein-
coupled receptors (GPCRs). Nuclear receptors are defined as intracellular ligand-inducible 
transcription factors, which modulate gene expression in response to hydrophobic 
endogenous and exogenous chemicals (Khan & Heuvel, 2003). Functions affected include the 
fatty acid metabolism, the reproductive development and the detoxification of substances 
(Khan & Heuvel, 2003). In general, nuclear receptors consist of distinct functional domains. 
The N-terminal A/B domain, has a weak transactivation activity (activation function 1 (AF-1)) 
(Bordoni et al., 2006; Khan & Heuvel, 2003). Adjacent there is the C domain, which is 
important for DNA binding (Bordoni et al., 2006; Khan & Heuvel, 2003). The DNA binding 
domain is the most conserved region of the nuclear receptor superfamily. It is composed of 
two zinc fingers, which bind to response elements (NREs) in their target promoters (Bordoni et 
al., 2006; Khan & Heuvel, 2003). The flanking D domain is a hinge region. This region may 
allow for conformational changes in the receptor structure following ligand binding (Bordoni 
et al., 2006; Khan & Heuvel, 2003). The C-terminal E/F domain contains the ligand binding 
site, which in every nuclear receptor is comprised of 10 to 13 ǂ-helixes that form a 
hydrophobic binding cavity (Bordoni et al., 2006; Khan & Heuvel, 2003). At the extreme C-
terminus there is the ligand-dependend transactivation function-2 (AF-2) (Bordoni et al., 2006; 
Khan & Heuvel, 2003). Furthermore, this region also contains nuclear localisation signals and 
protein interaction surfaces for dimerization with heat shock proteins, co-regulators and other 
transcription factors (Bordoni et al., 2006; Khan & Heuvel, 2003). 
So far, five transcription factor families have been described to be modulated in their 
activity by fatty acids: peroxisome proliferator-activated receptors (PPARs), retinoid X 
receptors (RXRs), liver X receptors (LXRs), the hepatic nuclear factor 4 ǂ (HNF-4ǂ) and 
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sterol regulatory element binding proteins (SREBPs) (Bordoni et al., 2006). The interaction 
between fatty acids and nuclear receptors is of importance in regulating lipid and glucose 
metabolism at this modulating the expression of specific enzymes as well as of fatty acid 
transporters (Bordoni et al., 2006). Beside, based on PPARs there is also a regulation of 
inflammation and immune response (Bishop-Bailey & Bystrom, 2009). 
PPARs were identified 1990 as transcription factors (Issemann & Green, 1990). In 1992 
linoleic acid (C18:2n6; table 2) and arachidonic acid were demonstrated to activate PPARs 
(Gottlicher et al., 1992). There are three PPAR family members: PPARǂ (NR1C1), PPARǃ/ǅ 
(NR1C2; NUC1; FAAR fatty acid-activated receptor) and PPARǄ (NR1C3). The isotypes are 
distinguished from each other by their tissue distribution and their differential activation 
(Grimaldi, 2001). PPARs are implicated in a number of biological processes, such as the 
regulation of lipid metabolism (uptake, activation, oxidation and esterification of fatty 
acids), development, cell proliferation and differentiation as well as inflammatory 
responses Escher & Wahli, 2000). PPARs exert their effects on gene expression as 
heterodimers with RXRs (Kliewer et al., 1992). The PPAR/RXR heterodimer binds to 
specific PPAR response elements (PPRE), which located in the promoter of target genes 
(Issemann et al., 1993). The consensus sequence consists of a direct repeat of the hexamer 
AGGTCA separated by single-nucleotide spacer, the so called direct repeat (DR-1) 
(Ijpenberg et al., 1997). The conformational change that occurs upon ligand binding leads 
to the dissociation of co-repressors as nuclear receptor co-repressor (NCoR) and silencing 
mediator for retinoid- and thyroid-hormone receptors (SMRT) (Feige et al., 2006). In 
addition, activated PPARs fascilitate the recruitment of co-activators, chromatin 
remodelling factors and of the transcription machinery (Bishop-Bailey & Bystrom, 2009). 
The activity of the PPARs can be modulated by phosporylation, nitration, ubiquitylation 
and sumoylation (Bordoni et al., 2006). 
PPARǂ is mainly expressed in liver, intestinal tract, kidney, heart and brown adipose tissue 
(Bordoni et al., 2006). The receptor is of importance in fatty acid transport and oxidation, cell 
proliferation and inflammatory crosstalk (Bordoni et al., 2006). Synthetic ligands of PPARǂ 
have been shown to impair cytokine synthesis of phorbol ester stimulated monocytes (Jiang 
at el., 1998). 
PPARǃ/ǅ is almost ubiquitously expressed (Bishop-Bailey & Bystrom, 2009). It is implicated 
in the fatty acid oxidation of many tissues (Bishop-Bailey & Bystrom, 2009). Furthermore, 
PPARǃ/ǅ has been reported to be involved in cell proliferation and development, wound 
healing, myelination of nerves as well as the adaptive response of skeletal muscle to exercise 
(Bordoni et al., 2006). In macrophages the receptor controls the inflammatory status at this 
diminishing the expression of pro-inflammatory cytokines and receptors as IL-1ǃ, IL-6, 
TNF-ǂ, macrophage inflammatory protein 1ǃ, the MCP-1 receptor CC-chemokine receptor-2 
and VCAM-1 (Bishop-Bailey & Bystrom, 2009). 
PPARǄ is expressed in various isoforms, which show tissue and differentiation specifity 
(Bishop-Bailey & Bystrom, 2009). The receptor plays a role in glucose homeostasis, lipid 
metabolism, cell proliferation and inflammation (Feige et al., 2006). PPARǄ is the 
predominant PPAR receptor expressed by cells of the myeloid line (Stulnig, 2003). It is 
essential for differentiation of adipocytes and macrophages (Khan & Heuvel, 2003). 
Expression of PPARǄ is upregulated during macrophage activation (Huang et al., 1999). 
Genes regulated include lipoprotein lipase, CD36 and scavenger receptors (Khan & Heuvel, 
2003; Yaqoob, 2003). As with PPARǂ, synthetic ligands of PPARǄ have been demonstrated 
to suppress production of IL-1ǃ, IL-6, TNF-ǂ as well as the inducible nitric oxide synthase 
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(iNOS), matrix metalloprotease-9 and scavenger receptor A (Jiang at el., 1998; Ricote et al., 
1998; Yang et al., 2000). PPARǄ is activated by unsaturated fatty acids, the prostaglandin 15-
deoxy PGJ2 and non-steriodal anti-inflammatory drugs (NSAIDS) (Grimaldi, 2005; Khan & 
Heuvel, 2003; Stulnig, 2003). 
Beside nuclear receptors recently five G protein-coupled receptors have been described, 
which can be activated by free fatty acids: GPR40 binding long-chain fatty acids, GPR41 
binding short-chain fatty acids, GPR43 binding short-chain fatty acids, GPR84 binding 
medium-chain fatty acids and GPR120 binding long-chain fatty acids (Oh et al., 2010). From 
the perspective of immune modulation GPR120 emerges as a receptor of particular interest. 
In contrast to the other receptors of the family of fatty acid sensing GPCRs GPR120 is the 
only one, which is highly expressed in adipose tissue and macrophages (Oh et al., 2010). 
Moreover, ligand stimulation of GPR120 by the n3 PUFA DHA and EPA has been reported 
to result in potent anti-inflammatory effects, including inhibition of IL-6, TNF-ǂ and MCP-1 
mRNA expression and secretion (Oh et al., 2010). Activation of GPR120 by n3 fatty acids 
leads to a coupling of GPR120 to the adaptor protein ǃ-arrestin2, which is followed by 
receptor and ǃ-arrestin2 internalization (Oh et al., 2010). In the cytoplasm the GPR120/ǃ-
arrestin2 complex can associate with the TGF-beta activated kinase 1 binding protein 1 
(TAB1) at this blocking the association of TAB1 with the TGF-beta activated kinase 1 (TAK1) 
(Oh et al., 2010). Thus, there is an inhibition of TAK1 activation and downstream signalling 
to the IKKǃ/NFκB and JNK/AP1 system resulting in the inhibition of Toll-like receptor 2/3 
and 4 as well as TNF-ǂ action (Oh et al., 2010). 
4.4 Fatty acid composition of cellular membranes 
The lipid composition of cellular membranes is known to depend on the availability of fatty 
acids (Calder et al., 1994). Supplementation of cells with PUFAs results in an incorporation 
of the fatty acids into membrane phospholipids (Schmutzler et al., 2010; Schumann & 
Fuhrmann, 2010; Walloschke et al., 2010). Beyond that, the PUFAs were metabolized leading 
to an increase of the desaturation and elongation products of the fatty acids added 
(Schmutzler et al., 2010; Schumann & Fuhrmann, 2010; Walloschke et al., 2009). The 
enhanced proportion of unsaturated fatty acids in the cell membrane is accompanied by a 
heightening of the Methylene Bridge Index (MBI) of the lipid bilayer and an increasing of 
membrane fluidity (Schmutzler et al., 2010; Schumann & Fuhrmann, 2010; Walloschke et al., 
2009). The MBI is calculated based on the ratio of a fatty acid (weight %) and the number of 
its bis-allyl-methylene positions (Kelley et al., 1995). The higher the MBI, the more fluid the 
membrane. Moreover, membranes with a heightened MBI are predicted to have an 
increased susceptibility against radical reactions (Kelley et al., 1995). 
The modulation of membrane fluidity makes an impact on the activity of membrane-bound 
enzymes and also on the function of membrane receptors thus affecting signal transduction 
(Benatti et al., 2004; Calder et al., 1994). Many key proteins of signal transduction, as Toll-
like receptors or Nod-like receptors, are localized in lipid rafts (Pike, 2003). After binding of 
the ligand, the activated receptor complexes are compartmentalized in the lipid rafts (Jury et 
al., 2007). At this, the lipid rafts facilitate the association of signal transduction molecules 
(Jury et al., 2007; Pike, 2003). 
The membrane fluidity necessary for an optimal cell response is assumed to fall within 
particular boundaries (Calder et al., 1994). Changes in the lipid composition of the plasma 
membrane therefore directly affect cellular reactions on signals from the environmental. 
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Accordingly, there is a correlation between the activity of immune cells and the fatty acid 
pattern of their cell membrane. 
Of note, the availability of fatty acids is modulated by the diet. The connection between the 
dietary intake of fatty acids and inflammation was first drawn in the late 1970s. 
Epidemiological observation showed that native Greenland Eskimos (Dyerberg & Bang, 
1979) and Japanese (Hirai et al, 1980), which have a high intake of n3 PUFA from seafood, 
have a low incidence for myocardial infarction, chronic inflammation and autoimmune 
disorders. To date, there are numerous studies, which have investigated the effects of the 
amount and the type of fat in the diet on cellular physiology (Calder, 2006b; Galli & Calder, 
2009). It is now well accepted that the fatty acid composition of body cells, including 
immune cells, is sensitive to alteration according to the fatty acid composition of the diet 
(Calder, 2001). In particular, proportions of PUFAs of the n3 and the n6 family are readily 
modified thus providing a link between dietary PUFA intake, inflammation and immunity 
(Calder, 2001). The findings from these studies led health care professionals to encourage 
the general population to consume more n3 fatty acids.  
5. Conclusion 
The importance of lipid bilayers for the overall processes of life is increasingly realized. 
Plasma membranes are just more than compartmentalization elements separating the inside 
of a cell from the surrounding environment. They have numerous functions in cell adhesion, 
ion conductivity and cell signalling acting as an attachment surface for intracellular and 
extracellular. 
Infection processes and immune defence greatly depend on cellular membrane interactions. 
In an initial step of infection pathogens, as bacteria and viruses, as well as bacterial toxins, 
need to get inside the host cell (Murphy et al., 2008). The internalization enables the 
pathogens to proliferate and to poison the cell (Murphy et al., 2008). Thus, the attachment of 
pathogens to cellular surfaces and the binding to a cell-surface receptor are critical in the 
course of infection processes. Moreover, the mutual communication between immune cells 
crucially depends on signal molecules binding to cellular receptors as well as on direct 
membrane-membrane interactions. Stimulation of membrane receptors via cytokines and 
chemokines and direct cell-cell contacts are of importance in activating immune cells thus 
triggering immune defence (Murphy et al., 2008). Likewise, completion of the immune 
response after successful extinction of the pathogens is mediated by membrane-dependent 
signal transduction processes (Murphy et al., 2008). A further mechanism in immune 
defence, which involves the interaction between the plasma membranes of both pathogen 
and host, is the phagocytosis of pathogens by macrophages and dendritic cells.  
Of note, membranes are very flexible in their overall composition. Depending on cell type 
and tissue the proportion of phospholipids and sphingolipids varies greatly. The same is the 
case with membrane proteins. There are numerous highly specialised mechanisms that 
allow for the particular allocation of membrane lipids and membrane proteins according to 
the requirements and functions of a cell. Beyond that, the lipid bilayer is characterized by an 
asymmetry in the distribution of phospholipids and sphingolipids between the inner and 
the outer leaflet (Löffler et al., 2007). This asymmetry is determined by the balance of 
specific transport proteins (Löffler et al., 2007). The disruption of the lipid asymmetry is a 
piece in the substrate recognition of macrophages (Löffler et al., 2007). 
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However, the lipid composition of cellular membranes, including immune cells, can be 
modulated depending on the availability of fatty acids, providing a link between the diet 
and the immune defence (Calder et al., 1994). In particular, highly unsaturated fatty acids 
are immediately incorporated into the lipid bilayer (Schumann & Fuhrmann, 2010). The 
physical properties of membranes are highly reliant on the fatty acid pattern. Features 
modulated include the fatty acid chain order, the phase behaviour, the elastic 
compressibility, the ion permeability, the fusion, the rapid flip-flop and several protein 
functions thus affecting cell signal transduction (Stillwell & Wassall, 2003; Wassall & 
Stillwell, 2008). Moreover, the unsaturated fatty acids of membrane phospholipids serve as 
substrate for the synthesis of lipid signal molecules, as eicosanoids, lipoxins, resolvins, 
protectins and marensins, which are known to efficiently modulate immune defence 
mechanisms (Bannenberg & Serhan, 2010; Kohli & Levy, 2009; Löffler et al., 2007; Norling & 
Serhan, 2010). Beside, the fatty acids also act as ligands for several nuclear receptors and G 
protein-coupled receptors thus directly influencing the immune system (Bordoni et al., 
2006). This key position of fatty acids, in particular of PUFAs of the n3 and the n6 family, 
makes them particular promising in the supportive therapy of chronic diseases linked to 
persistent pathogens. 
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